Aerie Pharmaceuticals Inc Média de recomendação
Qual é o Média de recomendação de Aerie Pharmaceuticals Inc?
O Média de recomendação de Aerie Pharmaceuticals Inc é 1.43
Qual é a definição de Média de recomendação?
A média da recomendação é a média das classificações dos analistas das ações, variando de 1,0 (compra forte) a 5,0 (venda forte).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Média de recomendação de empresas na Setor Health Care em NASDAQ em comparação com Aerie Pharmaceuticals Inc
O que Aerie Pharmaceuticals Inc faz?
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases. Aerie's first product, Rhopressa® (netarsudil ophthalmic solution) 0.02%, a once-daily eye drop approved by the U.S. Food and Drug Administration (FDA) for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension, was launched in the United States in April 2018. In clinical trials of Rhopressa®, the most common adverse reactions were conjunctival hyperemia, corneal verticillata, instillation site pain, and conjunctival hemorrhage. Aerie's second product for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension, Rocklatan® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%, the first and only fixed-dose combination of Rhopressa® and the widely-prescribed PGA (prostaglandin analog) latanoprost, was launched in the United States in May 2019. In clinical trials of Rocklatan®, the most common adverse reactions were conjunctival hyperemia, corneal verticillata, instillation site pain, and conjunctival hemorrhage. Aerie continues to focus on global expansion and the development of additional product candidates and technologies in ophthalmology, including for wet age-related macular degeneration and diabetic macular edema.
Empresas com média de recomendação semelhantes a Aerie Pharmaceuticals Inc
- LHC Inc tem Média de recomendação de 1.42
- Imax Corp tem Média de recomendação de 1.42
- TAL Education tem Média de recomendação de 1.42
- Coherent Corp tem Média de recomendação de 1.42
- Canadian Natural Resources tem Média de recomendação de 1.42
- Semtech tem Média de recomendação de 1.42
- Aerie Pharmaceuticals Inc tem Média de recomendação de 1.43
- Addus HomeCare tem Média de recomendação de 1.44
- Biolife Solutions Inc tem Média de recomendação de 1.44
- Visa Inc tem Média de recomendação de 1.44
- ServiceNow Inc tem Média de recomendação de 1.44
- Daqo New Corp tem Média de recomendação de 1.44
- ACM Research Inc tem Média de recomendação de 1.44